Figure 2 characterizes the signatures consisting of the top 50 lncRNAs and 50 miRNAs with the most cancer types for amplification. For 50 lncRNAs, cancer susceptibility candidate 11 (CASC11) is ranked the first, while two canonical oncogenic lncRNA, CCAT1 [34,35,36,37,38] and PVT1 [39,40,41], are ranked 9th and 12th respectively. This evidence concerns the gene CASC11 and cancer.